Carlos E. Parra-Herran, MD

Dr. Carlos E. Parra-Herran, MD, is an academic gynecologic pathologist at Brigham and Women’s Hospital and associate professor of Pathology at Harvard Medical School. He graduated from Universidad Nacional de Colombia and completed his residency at Jackson Memorial Hospital, followed by subspecialty training at Brigham and Women’s Hospital and Sunnybrook Health Sciences Centre. His research focuses on the morphologic and molecular characterization of gynecologic tract neoplasia, particularly epithelial lesions of the lower genital tract, mesenchymal tumors, and nonserous ovarian neoplasia. He has authored over 100 peer-reviewed journal articles (original research and reviews) and edited three reference textbooks: Gynecologic Pathology, a volume in the Foundations in Diagnostic Pathology series, 2nd edition, Elsevier, 2020; Gynecologic and Obstetric Pathology, an issue of Surgical Pathology Clinics, Volume 15(2), Elsevier, 2022; and Tumors of the Cervix, Vagina, and Vulva in Atlases of Tumor and Non-Tumor Pathology, Series 5, American Registry of Pathology, 2023. He has served as teaching faculty for regional, national, and international continuing medical education events. He is also part of the organizing team for the International Society of Gynecological Pathologists (ISGyP) Live Virtual Education program. Dr. Parra-Herran currently serves as a member of the ISGyP board of directors and the United States and Canadian Academy of Pathology (USCAP) education committee.

Carlos E. Parra-Herran, MD

Dr. Carlos E. Parra-Herran, MD, is an academic gynecologic pathologist at Brigham and Women’s Hospital and associate professor of Pathology at Harvard Medical School. He graduated from Universidad Nacional de Colombia and completed his residency at Jackson Memorial Hospital, followed by subspecialty training at Brigham and Women’s Hospital and Sunnybrook Health Sciences Centre. His research focuses on the morphologic and molecular characterization of gynecologic tract neoplasia, particularly epithelial lesions of the lower genital tract, mesenchymal tumors, and nonserous ovarian neoplasia. He has authored over 100 peer-reviewed journal articles (original research and reviews) and edited three reference textbooks: Gynecologic Pathology, a volume in the Foundations in Diagnostic Pathology series, 2nd edition, Elsevier, 2020; Gynecologic and Obstetric Pathology, an issue of Surgical Pathology Clinics, Volume 15(2), Elsevier, 2022; and Tumors of the Cervix, Vagina, and Vulva in Atlases of Tumor and Non-Tumor Pathology, Series 5, American Registry of Pathology, 2023. He has served as teaching faculty for regional, national, and international continuing medical education events. He is also part of the organizing team for the International Society of Gynecological Pathologists (ISGyP) Live Virtual Education program. Dr. Parra-Herran currently serves as a member of the ISGyP board of directors and the United States and Canadian Academy of Pathology (USCAP) education committee.

Anna M. Shestakova, MD, PhD

Dr. Anna Shestakova is a medical director of Hematopathology and Molecular Genetic Pathology at ARUP Laboratories and an assistant professor (clinical) at the University of Utah School of Medicine. She received a medical degree from Bogomolets National Medical University and a doctorate degree from the University of Utah. She completed a residency in anatomical and clinical pathology at the University of California, Irvine School of Medicine, and she completed fellowships in hematopathology at the University of Michigan and molecular genetic pathology at the University of Utah School of Medicine. Dr. Shestakova is certified by the American Board of Pathology in anatomic and clinical pathology and hematopathology. She is also a member of the Educational Commission for Foreign Medical Graduates. Her research interests include small lymphocytic lymphoma (SLL), chronic lymphocytic leukemia (CLL), and the role of TP53 in the clonal evolution of lymphoid and myeloid neoplasms.

Carlos E. Parra-Herran, MD

Dr. Carlos E. Parra-Herran, MD, is an academic gynecologic pathologist at Brigham and Women’s Hospital and associate professor of Pathology at Harvard Medical School. He graduated from Universidad Nacional de Colombia and completed his residency at Jackson Memorial Hospital, followed by subspecialty training at Brigham and Women’s Hospital and Sunnybrook Health Sciences Centre. His research focuses on the morphologic and molecular characterization of gynecologic tract neoplasia, particularly epithelial lesions of the lower genital tract, mesenchymal tumors, and nonserous ovarian neoplasia. He has authored over 100 peer-reviewed journal articles (original research and reviews) and edited three reference textbooks: Gynecologic Pathology, a volume in the Foundations in Diagnostic Pathology series, 2nd edition, Elsevier, 2020; Gynecologic and Obstetric Pathology, an issue of Surgical Pathology Clinics, Volume 15(2), Elsevier, 2022; and Tumors of the Cervix, Vagina, and Vulva in Atlases of Tumor and Non-Tumor Pathology, Series 5, American Registry of Pathology, 2023. He has served as teaching faculty for regional, national, and international continuing medical education events. He is also part of the organizing team for the International Society of Gynecological Pathologists (ISGyP) Live Virtual Education program. Dr. Parra-Herran currently serves as a member of the ISGyP board of directors and the United States and Canadian Academy of Pathology (USCAP) education committee.

Carlos E. Parra-Herran, MD

Dr. Carlos E. Parra-Herran, MD, is an academic gynecologic pathologist at Brigham and Women’s Hospital and associate professor of Pathology at Harvard Medical School. He graduated from Universidad Nacional de Colombia and completed his residency at Jackson Memorial Hospital, followed by subspecialty training at Brigham and Women’s Hospital and Sunnybrook Health Sciences Centre. His research focuses on the morphologic and molecular characterization of gynecologic tract neoplasia, particularly epithelial lesions of the lower genital tract, mesenchymal tumors, and nonserous ovarian neoplasia. He has authored over 100 peer-reviewed journal articles (original research and reviews) and edited three reference textbooks: Gynecologic Pathology, a volume in the Foundations in Diagnostic Pathology series, 2nd edition, Elsevier, 2020; Gynecologic and Obstetric Pathology, an issue of Surgical Pathology Clinics, Volume 15(2), Elsevier, 2022; and Tumors of the Cervix, Vagina, and Vulva in Atlases of Tumor and Non-Tumor Pathology, Series 5, American Registry of Pathology, 2023. He has served as teaching faculty for regional, national, and international continuing medical education events. He is also part of the organizing team for the International Society of Gynecological Pathologists (ISGyP) Live Virtual Education program. Dr. Parra-Herran currently serves as a member of the ISGyP board of directors and the United States and Canadian Academy of Pathology (USCAP) education committee.

H. Evin Gulbahce, MD, MSCI

Dr. H. Evin Gulbahce is the subspecialty director of breast pathology at ARUP Laboratories and a professor at the University of Utah School of Medicine. Dr. Gulbahce received his medical degree from Hacettepe University School of Medicine. He then completed an anatomic and clinical pathology residency and a surgical pathology fellowship at the University of Minnesota. Dr. Gulbahce is certified in anatomic and clinical pathology by the American Board of Pathology. He has received the Clinical Excellence award and the Outstanding Teaching award from the Department of Pathology at the University of Utah.

Allison Cleary, MD, PhD

Dr. Allison Cleary is a pathologist at ARUP Laboratories, and an assistant professor (clinical) for the University of Utah School of Medicine. Dr. Cleary received her MD and PhD from the Pennsylvania State University College of Medicine. She completed her residency in anatomic and clinical pathology at the Brigham and Women’s Hospital, where she also served as chief resident. She then went on to complete a fellowship in breast pathology at Brigham and Women’s Hospital. Dr. Cleary is board certified in anatomic and clinical pathology. Her research interests include tumor heterogeneity and breast diseases.

Daniel Albertson, MD

Dr. Daniel Albertson is an associate professor (clinical) at the University of Utah School of Medicine and currently serves as the division chief for Anatomic Pathology and Molecular Oncology. He previously served as the section head for Surgical Pathology as well as the head of Genitourinary Pathology. He received his MD from the University of Nebraska and completed his residency in anatomic and clinical pathology at Creighton University, followed by a surgical pathology fellowship at the University of Utah. While at Creighton, Dr. Albertson served as the chief resident for two years and received the Hal Lankford Pathology Resident Award. He is a member of United States and Canadian Academy of Pathology and the College of American Pathologists. Dr. Albertson’s special research interests include oncologic genitourinary, gynecologic, and solid tumor pathology.

Elke Jarboe, MD

Dr. Elke Jarboe is an associate professor at the University of Utah School of Medicine. She received her medical degree from and completed her anatomic pathology residency training at the University of Colorado School of Medicine. Subsequently, she completed fellowships in women’s and perinatal pathology and cytopathology at Brigham and Women’s Hospital in Boston. Her primary subspecialty and research interest is in gynecologic pathology. Dr. Jarboe is a member of the editorial board for the International Journal of Gynecological Pathology and the cytopathology section editor for the American Journal of Clinical Pathology.

Anton Rets, MD, PhD

Dr. Anton Rets is a medical director of Hematopathology at ARUP Laboratories and an assistant professor (clinical) at the University of Utah School of Medicine. Dr. Rets received a doctorate degree in pathology from Perm State Medical Academy/St. Petersburg Academy of Postgraduate Medical Education. He then earned his medical degree and completed a pathology residency at Perm State Medical Academy. He also completed an anatomic and clinical pathology residency at the State University of New York Downstate Medical Center before completing a hematopathology fellowship at the University of Utah School of Medicine. Dr. Rets is board certified in anatomic and clinical pathology and hematopathology. He has received several awards, including the Outstanding Teaching award in clinical pathology, the Excellence in Leadership award, and the Outstanding Academic Performance Federal award. His research interests include red blood cell disorders, mast cell disorders, nonneoplastic hematology, and digital microscopy.

Laura C. Collins, MD

Dr. Laura C. Collins is the vice chair of Anatomic Pathology and director of Breast Pathology at Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts. She is a professor of Pathology at Harvard Medical School. Dr. Collins graduated from Charing Cross and Westminster Medical School in London and completed her anatomic and clinical pathology residency training at the Beth Israel Hospital in Boston, followed by a cytopathology fellowship at the same institution (now BIDMC). In 1998, Dr. Collins joined the faculty at BIDMC as a staff pathologist. During her tenure at BIDMC, she has served as the director of the residency training program in anatomic and clinical pathology as well as the director of the selective pathology fellowship training program. Nationally, she has served the United States and Canadian Academy of Pathology (USCAP) as a member of the Education Committee, chair of the Residency Advisory Subcommittee, and most recently, as a member of the USCAP board of directors. She has also served as the president of the Arthur Purdy Stout Society of Surgical Pathologists.

Dr. Collins is an internationally renowned breast pathologist. She has published numerous original articles, review articles, and book chapters on breast pathology. She has twice been the guest editor for a monograph on Current Concepts in Breast Pathology in the Surgical Pathology Clinics Series. She coauthored the popular pathology textbook entitled, Biopsy Interpretation of the Breast, which is now in its third edition, and she was a contributor to several chapters in the WHO Classification of Tumours of the Breast, 4th edition, published in 2012, and Breast Tumours: WHO Classification of Tumours, 5th edition, published in 2019.

Her research interests are in breast cancer, and in particular, the understanding of precursor lesions and early breast neoplasia. In addition to her work in research, Dr. Collins is a committed educator, giving numerous lectures and postgraduate CME courses around the U.S. and the world to support the ongoing education of pathologists and pathologists-in-training in the diagnosis of breast disease.

Mei Wei, MD

Dr. Mei Wei is a medical oncologist and assistant professor (clinical) at the Huntsman Cancer Institute, University of Utah. Dr. Wei received her medical degree from Anhui Medical University. She completed residencies in gynecological oncology and radiation oncology Sun Yat-sen University Cancer Center, a postdoctoral research fellowship in cancer epidemiology at the University of Utah School of Medicine, an internship in internal medicine at the University of Nevada, Reno School of Medicine, a residency in internal medicine at the University of Utah School of Medicine, and a fellowship in hematology/oncology at the University of Utah School of Medicine. Dr. Wei focuses her practice on breast oncology with clinical research interests in clinical trials and breast cancer outcomes.

Laura C. Collins, MD

Dr. Laura C. Collins is the vice chair of Anatomic Pathology and director of Breast Pathology at Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts. She is a professor of Pathology at Harvard Medical School. Dr. Collins graduated from Charing Cross and Westminster Medical School in London and completed her anatomic and clinical pathology residency training at the Beth Israel Hospital in Boston, followed by a cytopathology fellowship at the same institution (now BIDMC). In 1998, Dr. Collins joined the faculty at BIDMC as a staff pathologist. During her tenure at BIDMC, she has served as the director of the residency training program in anatomic and clinical pathology as well as the director of the selective pathology fellowship training program. Nationally, she has served the United States and Canadian Academy of Pathology (USCAP) as a member of the Education Committee, chair of the Residency Advisory Subcommittee, and most recently, as a member of the USCAP board of directors. She has also served as the president of the Arthur Purdy Stout Society of Surgical Pathologists.

Dr. Collins is an internationally renowned breast pathologist. She has published numerous original articles, review articles, and book chapters on breast pathology. She has twice been the guest editor for a monograph on Current Concepts in Breast Pathology in the Surgical Pathology Clinics Series. She coauthored the popular pathology textbook entitled, Biopsy Interpretation of the Breast, which is now in its third edition, and she was a contributor to several chapters in the WHO Classification of Tumours of the Breast, 4th edition, published in 2012, and Breast Tumours: WHO Classification of Tumours, 5th edition, published in 2019.

Her research interests are in breast cancer, and in particular, the understanding of precursor lesions and early breast neoplasia. In addition to her work in research, Dr. Collins is a committed educator, giving numerous lectures and postgraduate CME courses around the U.S. and the world to support the ongoing education of pathologists and pathologists-in-training in the diagnosis of breast disease.

Laura C. Collins, MD

Dr. Laura C. Collins is the vice chair of Anatomic Pathology and director of Breast Pathology at Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts. She is a professor of Pathology at Harvard Medical School. Dr. Collins graduated from Charing Cross and Westminster Medical School in London and completed her anatomic and clinical pathology residency training at the Beth Israel Hospital in Boston, followed by a cytopathology fellowship at the same institution (now BIDMC). In 1998, Dr. Collins joined the faculty at BIDMC as a staff pathologist. During her tenure at BIDMC, she has served as the director of the residency training program in anatomic and clinical pathology as well as the director of the selective pathology fellowship training program. Nationally, she has served the United States and Canadian Academy of Pathology (USCAP) as a member of the Education Committee, chair of the Residency Advisory Subcommittee, and most recently, as a member of the USCAP board of directors. She has also served as the president of the Arthur Purdy Stout Society of Surgical Pathologists.

Dr. Collins is an internationally renowned breast pathologist. She has published numerous original articles, review articles, and book chapters on breast pathology. She has twice been the guest editor for a monograph on Current Concepts in Breast Pathology in the Surgical Pathology Clinics Series. She coauthored the popular pathology textbook entitled, Biopsy Interpretation of the Breast, which is now in its third edition, and she was a contributor to several chapters in the WHO Classification of Tumours of the Breast, 4th edition, published in 2012, and Breast Tumours: WHO Classification of Tumours, 5th edition, published in 2019.

Her research interests are in breast cancer, and in particular, the understanding of precursor lesions and early breast neoplasia. In addition to her work in research, Dr. Collins is a committed educator, giving numerous lectures and postgraduate CME courses around the U.S. and the world to support the ongoing education of pathologists and pathologists-in-training in the diagnosis of breast disease.

Jonathon Mahlow, MD

Dr. Jonathon Mahlow is a staff pathologist at ARUP and an assistant professor (clinical) at the University of Utah School of Medicine. He received his MD from Wayne State School of Medicine in Detroit and completed his anatomic and clinical pathology residency training at the Cleveland Clinic Foundation. Subsequently, he completed a fellowship in surgical pathology at the University of Utah. Dr. Mahlow is a member of several professional societies, including the United States and Canadian Academy of Pathology and the American Society for Clinical Pathology.

Ana Lucia Ruano, MD

Dr. Ana Lucia Ruano is a pathologist at ARUP Laboratories and an assistant professor (clinical) at the University of Utah School of Medicine. Dr. Ruano graduated from the Universidad Francisco Marroquin with her medical degree. She completed an anatomic and clinical pathology residency at the Cleveland Clinic, as well as fellowships in pediatric pathology at the University of Utah School of Medicine, hematopathology at the Cleveland Clinic, and surgical pathology at the Roswell Park Comprehensive Cancer Center. Dr. Ruano is certified by the American Board of Pathology. She specializes in breast pathology and molecular oncology PDL-1 testing.

Lesley C. Lomo, MD

Dr. Lesley C. Lomo is a pathologist at ARUP Laboratories and an associate professor (clinical) at the University of Utah School of Medicine. She received her medical degree from Wayne State University School of Medicine in Detroit and completed her residency in anatomic and clinical pathology, as well as fellowships in women’s and perinatal pathology, breast pathology, and cytopathology at Brigham and Women’s Hospital in Boston. Dr. Lomo is board certified in anatomic and clinical pathology and cytopathology. She is a member of several professional organizations, including the United States and Canadian Academy of Pathology, the American Society for Clinical Pathology, and the International Society of Gynecological Pathologists. Her research interests include education techniques for pathology trainees and medical students, neoplastic and nonneoplastic endometrial pathology, and biomarkers of malignancy risk in preneoplastic epithelial breast disease.

Valarie McMurtry, MD, PhD

Dr. Valarie McMurtry completed her undergraduate degree at the University of Oklahoma, followed by her medical degree and doctorate degree from Louisiana State University. Dr. McMurtry is certified by the American Board of Pathology in anatomic and clinical pathology.

Jolanta Jedrzkiewicz, MD

Dr. Jolanta Jedrzkiewicz is a pathologist at ARUP Laboratories and an assistant professor (clinical) at the University of Utah. Dr. Jedrzkiewicz received her medical degree from Poznan University of Medical Sciences and then completed an anatomic and clinical pathology residency at the University of Utah. She then completed a surgical pathology fellowship at MD Anderson and a gastrointestinal pathology fellowship at Mount Sinai Hospital. Dr. Jedrzkiewicz is board certified, and her research interests include diseases of the gastrointestinal tract with special interest in tumors of the appendix.

Michael Balatico, MD, MFA

Dr. Michael Balatico is a pathologist at ARUP Laboratories, and an assistant professor (clinical) at the University of Utah School of Medicine. He received a medical degree from the Indiana University School of Medicine and a Master of Fine Arts from the School of the Art Institute of Chicago. He completed a residency in anatomic and clinical pathology and a fellowship in cytopathology from the University of Utah School of Medicine. Dr. Balatico is board certified by the American Board of Pathology in anatomic and clinical pathology. He received the Resident Teaching Award in 2021 and the Lester Corser Humanitarian Award in 2020. His research interests include breast pathology and genitourinary pathology.

Margaret Williams, MD

Dr. Margaret Williams is a medical director of Hematopathology at ARUP Laboratories, and an assistant professor (clinical) for the University of Utah School of Medicine. She received her medical degree from the University of North Carolina School of Medicine. She completed a residency in anatomic and clinical pathology from the University of Utah School of Medicine and a fellowship in hematopathology and molecular genetic pathology from the University of Utah School of Medicine. Dr. Williams is certified by the American Board of Pathology in anatomic and clinical pathology and hematopathology. Her research interests include molecular findings in hematologic malignancies and quality improvement.